title: Effect of COMT Val(158)Met genotype on nicotine withdrawal-related cognitive dysfunction in smokers with and without schizophrenia.
authors.affiliation: Division of Brain and Therapeutics, Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Schizophrenia Division, Complex Mental Illness, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada. Electronic address: vicky.wing@camh.ca.
authors.forename: Victoria C
authors.initials: VC
authors.lastname: Wing
authors.forename: Yi-Lang
authors.initials: YL
authors.lastname: Tang
authors.forename: Kristi A
authors.initials: KA
authors.lastname: Sacco
authors.forename: Joseph F
authors.initials: JF
authors.lastname: Cubells
authors.forename: Tony P
authors.initials: TP
authors.lastname: George
mesh_terms: D000704:Analysis of Variance; D002394:Catechol O-Methyltransferase / Q000235:genetics*; D005260:Female; D005838:Genotype; D006801:Humans; D008297:Male; D008715:Methionine / Q000235:genetics; D012559:Schizophrenia / Q000150:complications* / Q000235:genetics*; D012565:Schizophrenic Psychology; D012907:Smoking / Q000523:psychology*; D014029:Tobacco Use Disorder / Q000150:complications / Q000235:genetics*; D014633:Valine / Q000235:genetics
chemical_list: D008715:Methionine; D002394:Catechol O-Methyltransferase; D014633:Valine